Etrolizumab-s Does Not Induce Residual Trafficking of Regulatory T Cells. Schweda A, Becker E, Wiendl M, Atreya R, et al. Inflamm Bowel Dis 2022;28:1746-1755.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Schweda A, Becker E, Wiendl M, Atreya R, et al. Etrolizumab-s Does Not Induce Residual Trafficking of Regulatory T Cells. Inflamm Bowel Dis 2022;28:1746-1755.
PMID: 35815779